Lack of Increased Hepatotoxicity in HIV-infected Pregnant Women Receiving Nevirapine Compared to Other Antiretrovirals

Ítems similars

• Increased Risk of Hepatotoxicity in HIV-infected Pregnant Women Receiving Antiretroviral Therapy Independent of Nevirapine Exposure
  per: Ouyang, David W., et al.
  Publicat: (2009)
• Postpartum Antiretroviral Drug Resistance in HIV-1-infected Women Receiving Pregnancy-Limited Antiretroviral Therapy
  per: Paredes, Roger, et al.
  Publicat: (2010)
• Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
  per: Aaron, Erika, et al.
  Publicat: (2010)
• A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine
  per: Van Dyke, Russell B., et al.
  Publicat: (2012)
• Lack of Antimicrobial Activity by the Antiretroviral Drug Nevirapine against Common Bacterial Pathogens
  per: Jackson, J. Brooks, et al.
  Publicat: (2009)